InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference
InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc), the leading medical cannabis company outside of North America, today announced that it will participate in the Canaccord Genuity 8th Annual Global Cannabis Conference.
- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc), the leading medical cannabis company outside of North America, today announced that it will participate in the Canaccord Genuity 8th Annual Global Cannabis Conference.
- The conference is scheduled for tomorrow, May 23, 2024, at the Westin NY Grand Central Hotel in New York City.
- This prestigious event will bring together senior management teams from leading cannabis companies including InterCure CEO Alex Rabinovitch, to engage in panel discussions, fireside chats, and one-on-one meetings.
- For more information about the event please refer to the following link: